Citation

Pero JE, Rossi MA, Lehman HDGF, Kelly MJ, Mulhearn JJ, Wolkenberg SE, Cato MJ, Clements MK, Daley CJ, Filzen T, Finger EN, Gregan Y, Henze DA, Jovanovska A, Klein R, Kraus RL, Li Y, Liang A, Majercak JM, Panigel J, Urban MO, Wang J, Wang YH, Houghton AK, Layton ME.: Benzoxazolinone aryl sulfonamides as potent, selective Na_v1.7 inhibitors with in vivo efficacy in a preclinical pain model. Bioorg Med Chem Lett, Volume 27 (12), 2017

Authors

Cato MJ, Clements MK, Daley CJ, Filzen T, Finger EN, Gregan Y, Henze DA, Houghton AK, Jovanovska A, Kelly MJ, Klein R, Kraus RL, Layton ME., Lehman HDGF, Li Y, Liang A, Majercak JM, Mulhearn JJ, Panigel J, Pero JE, Rossi MA, Urban MO, Wang J, Wang YH, Wolkenberg SE

Journal

Bioorg Med Chem Lett

Year

2017

DOI

10.1016/j.bmcl.2017.04.040

PubMed

28465103

Machine-readable

REST APIRDF